Scarica l'app Stockscreener
9.10
3.91%
-0.37
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RCEL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$9.47
Aprire:
$9.44
Volume 24 ore:
109.42K
Relative Volume:
0.72
Capitalizzazione di mercato:
$238.58M
Reddito:
$50.14M
Utile/perdita netta:
$-35.38M
Rapporto P/E:
-6.50
EPS:
-1.4
Flusso di cassa netto:
$-39.46M
1 W Prestazione:
-2.36%
1M Prestazione:
-28.91%
6M Prestazione:
-7.14%
1 anno Prestazione:
-45.70%
Intervallo 1D:
$9.05
$9.5029
Intervallo di 1 settimana:
$9.00
$9.71
Portata 52W:
$7.51
$18.93
Avita Medical Inc Stock (RCEL) Company Profile
Nome
Avita Medical Inc
Settore
Industria
Telefono
661-568-1317
Indirizzo
28159 AVENUE STANFORD, VALENCIA, CA
Confronta RCEL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
9.10 | 238.58M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
127.93 | 221.89B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
102.36 | 150.86B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.29 | 149.17B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
72.45 | 42.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-24 | Iniziato | D. Boral Capital | Buy |
| 2024-04-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-03-02 | Iniziato | Piper Sandler | Overweight |
| 2020-08-27 | Iniziato | BofA Securities | Buy |
| 2020-04-21 | Iniziato | Oppenheimer | Outperform |
| 2020-03-03 | Iniziato | BTIG Research | Buy |
Mostra tutto
Avita Medical Inc Borsa (RCEL) Ultime notizie
AVITA Medical (NASDAQ:RCEL) adds US$24m to market cap in the past 7 days, though investors from five years ago are still down 81% - Simply Wall St
Avita medical director Suzanne Crowe buys $6,390 in stock - Investing.com
(RCEL) Investment Report - Stock Traders Daily
Avita Gets FDA Nod For Device - San Fernando Valley Business Journal
Wound Skin Substitutes Market Forecast to 2030: Chronic Wound Burden Spurs Growth in Advanced Wound Care Technologies - Yahoo Finance
FY2024 EPS Forecast for AVITA Medical Decreased by Analyst - Defense World
Cantor Fitzgerald Expects Weaker Earnings for AVITA Medical - MarketBeat
Brokers Set Expectations for AVITA Medical FY2025 Earnings - Defense World
Cantor Fitzgerald Predicts AVITA Medical FY2025 Earnings - MarketBeat
Burns Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma, Avita Medical, Vericel Corp - The Globe and Mail
AVITA Medical's shares sink 19% after another forecast cut - MSN
Short Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Rises By 25.9% - MarketBeat
AVITA Medical, Inc. (NASDAQ:RCEL) Holdings Boosted by Barclays PLC - Defense World
Barclays PLC Grows Stock Holdings in AVITA Medical, Inc. (NASDAQ:RCEL) - MarketBeat
(RCEL) Investment Analysis - Stock Traders Daily
Why Avita Medical, Cettire, Domino's Pizza, and Star shares are falling today - MSN
AVITA Medical’s Growth Struggles Amplify Financial Risks (NASDAQ:RCEL) - Seeking Alpha
Investors Burned By AVITA Medical's Sales Miss: I'm Even More Bullish - Seeking Alpha
AVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO Mini - Seeking Alpha
Lake Street Capital Issues Pessimistic Forecast for AVITA Medical (NASDAQ:RCEL) Stock Price - Defense World
D. Boral Capital Reiterates Buy Rating for AVITA Medical (NASDAQ:RCEL) - Defense World
ASX shares plunge but remain undervalued - Morningstar.com.au
AVITA Medical, Inc. (RCEL): A Bull Case Theory - Insider Monkey
AVITA Medical's SWOT analysis: regenerative medicine stock faces growth hurdles - Investing.com Australia
AVITA Medical’s SWOT analysis: regenerative medicine stock faces growth hurdles - Investing.com Nigeria
AVITA Medical's SWOT analysis: regenerative medicine stock faces growth hurdles By Investing.com - Investing.com South Africa
Why AVITA Medical, Lovisa, Star, and Westgold shares are sinking today - The Motley Fool Australia
Lake Street cuts Avita Medical stock target, retains buy rating By Investing.com - Investing.com Canada
Avita falls 19% on earnings downgrade - Geelong Advertiser
AVITA Medical (NASDAQ:RCEL) Price Target Cut to $14.00 by Analysts at Lake Street Capital - MarketBeat
Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals - Benzinga
AVITA Medical Cuts Forecast Again, Shares Tumble - Finimize
AVITA Medical Shares Slump on Lowered Outlook - MarketWatch
AVITA Medical's (RCEL) "Buy" Rating Reiterated at D. Boral Capital - MarketBeat
Investors wipe $110m off AVITA Medical shares as full-year revenue target downgraded - Business News Australia
Australian Shares Rise as November Inflation Data Signals Easing Potential; Avita Medical Lowers Revenue Guidance - Marketscreener.com
Why AVITA Medical, Block, Computershare, and GQG Partners shares are falling today - MSN
AVITA Medical stock slides 14% on lowered guidance - MSN
AVITA Medical (ASX:AVH) Updates Q4 and FY2024 Revenue Guidance - The Capital Club
Avita Medical Inc Azioni (RCEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):